Europe Rat Model Market Size, Share & Forecast by 2022-2028

Europe Rat Model Market Size, Share & Industry Trends Analysis Report By Technology, By Type, By Service, By Application (Toxicology, Oncology, Immunology, and Neurology & Others), By End-use, By Country and Growth Forecast, 2022 - 2028

Published Date: October-2022 | Number of Pages: 104 | Format: PDF | Report ID: KBV-21077

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Rat Model Market, by Technology
1.4.2 Europe Rat Model Market, by Type
1.4.3 Europe Rat Model Market, by Service
1.4.4 Europe Rat Model Market, by Application
1.4.5 Europe Rat Model Market, by End-use
1.4.6 Europe Rat Model Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Rat Model Market by Technology
3.1 Europe CRISPR/CAS & Others Market by Country
3.2 Europe Nuclear transferase Market by Country
3.3 Europe Embryonic Stem Cell & Microinjection Market by Country

Chapter 4. Europe Rat Model Market by Type
4.1 Europe Outbred Market by Country
4.2 Europe Hybrid Market by Country
4.3 Europe Knockout Market by Country
4.4 Europe Inbred Market by Country
4.5 Europe Immunodeficient Market by Country
4.6 Europe Conditioned Market by Country

Chapter 5. Europe Rat Model Market by Service
5.1 Europe Breeding Market by Country
5.2 Europe Genetic testing Market by Country
5.3 Europe Cryopreservation Market by Country
5.4 Europe Re-derivation Market by Country
5.5 Europe Quarantine Depending & Others Market by Country

Chapter 6. Europe Rat Model Market by Application
6.1 Europe Toxicology Market by Country
6.2 Europe Oncology Market by Country
6.3 Europe Immunology Market by Country
6.4 Europe Neurology & Others Market by Country

Chapter 7. Europe Rat Model Market by End-use
7.1 Europe CROs Market by Country
7.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.3 Europe Academic & Research Institutes Market by Country

Chapter 8. Europe Rat Model Market by Country
8.1 Germany Rat Model Market
8.1.1 Germany Rat Model Market by Technology
8.1.2 Germany Rat Model Market by Type
8.1.3 Germany Rat Model Market by Service
8.1.4 Germany Rat Model Market by Application
8.1.5 Germany Rat Model Market by End-use
8.2 UK Rat Model Market
8.2.1 UK Rat Model Market by Technology
8.2.2 UK Rat Model Market by Type
8.2.3 UK Rat Model Market by Service
8.2.4 UK Rat Model Market by Application
8.2.5 UK Rat Model Market by End-use
8.3 France Rat Model Market
8.3.1 France Rat Model Market by Technology
8.3.2 France Rat Model Market by Type
8.3.3 France Rat Model Market by Service
8.3.4 France Rat Model Market by Application
8.3.5 France Rat Model Market by End-use
8.4 Russia Rat Model Market
8.4.1 Russia Rat Model Market by Technology
8.4.2 Russia Rat Model Market by Type
8.4.3 Russia Rat Model Market by Service
8.4.4 Russia Rat Model Market by Application
8.4.5 Russia Rat Model Market by End-use
8.5 Spain Rat Model Market
8.5.1 Spain Rat Model Market by Technology
8.5.2 Spain Rat Model Market by Type
8.5.3 Spain Rat Model Market by Service
8.5.4 Spain Rat Model Market by Application
8.5.5 Spain Rat Model Market by End-use
8.6 Italy Rat Model Market
8.6.1 Italy Rat Model Market by Technology
8.6.2 Italy Rat Model Market by Type
8.6.3 Italy Rat Model Market by Service
8.6.4 Italy Rat Model Market by Application
8.6.5 Italy Rat Model Market by End-use
8.7 Rest of Europe Rat Model Market
8.7.1 Rest of Europe Rat Model Market by Technology
8.7.2 Rest of Europe Rat Model Market by Type
8.7.3 Rest of Europe Rat Model Market by Service
8.7.4 Rest of Europe Rat Model Market by Application
8.7.5 Rest of Europe Rat Model Market by End-use

Chapter 9. Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.2 Laboratory Corporation of America Holdings
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Acquisition and Mergers:
9.3 Inotiv, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 genOway
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Janvier Labs
9.5.1 Company Overview
9.6 Taconic Biosciences, Inc. (H.I.G. Capital)
9.6.1 Company Overview
9.7 TransViragen, Inc.
9.7.1 Company Overview
9.8 Biomedical Research Models, Inc. (Biomere)
9.8.1 Company Overview
9.9 Cyagen Biosciences
9.9.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities